secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001628280-22-029364
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD reports Q4 adjusted EPS $2.75, up 27.9%; raises dividend 4.6% for 51st year
------------------------------------------------------------------------------

- Q4 revenue $4,761M, down 1.8% reported, +2.3% currency-neutral; base revenue +8.6% currency-neutral.
- Q4 GAAP diluted EPS $0.92; adjusted diluted EPS $2.75, up 27.9% YoY (36.3% currency-neutral).
- FY22 revenue $18.9B, adjusted EPS $11.35; base revenue +9.4% currency-neutral.
- Issues FY23 guidance; dividend raised 4.6%, marking 51st consecutive annual increase.
- Launched BD® Research Cloud and BD Effivax™; agreement with Biocorp for connected injectable therapies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828022029364/0001628280-22-029364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828022029364/bdx-20221110.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-029364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer